Alzheimer's trial brings at-risk patients hope for the futur

Could a new model of testing and drugs make this brain disease as treatable as Type 2 diabetes? As researchers run tests to find out, neuroscience is divided on what to do for now

Related Keywords

Toronto , Ontario , Canada , Germany , Ottawa , Japan , United States , United Kingdom , Amsterdam , Noord Holland , Netherlands , China , Canadians , Americans , German , Canadian , Britain , American , Sharon Cohen , Whitney Haller , Jason Karlawish , Byravi Sivasubramaniam , Lynn Zimmerman , Suzanne Schindler , Tyson Haller , Andrew Frank , John Mann , Clifford Jack , Jennifer Watt , Eli Lilly , Howard Chertkow , Alois Alzheimer , Health Canada , Alzheimer Association , American Geriatrics Society , Canadian Consortium On Neurodegeneration , Us Alzheimer Association , University Of Pennsylvania , Japan Eisai Co , Toronto Memory Program , Canadian Medical Association Journal , U Biogen Inc , Memory Program , Penn Memory Center , Washington University School Of Medicine , Baycrest Health Sciences , Log Increate Free , Toronto Memory , Canadian Consortium , Washington University School , Earlier Alzheimer , Mayo Clinic , Appwebview , Aud Url , Yesapplenews , Aud Headline , Alzheimer , Disease , Lecanemab , People , Drug , Dementia , Trial , Decline , St Michael X27s Hospital ,